CINEMARK HOLDINGS INC (CNK)

US17243V1026 - Common Stock

18.12  -0.01 (-0.06%)

After market: 18.12 0 (0%)

Buy % Consensus

72

ChartMill assigns a Buy % Consensus number of 72% to CNK. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 18.26. This target is 0.76% above the current price.
CNK was analyzed by 15 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about CNK.
In the previous month the buy percentage consensus was at a similar level.
CNK was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 18.1213.1318.8718.2625.20 - -27.54% 4.14% 0.76% 39.07%
Up and Down Grades
Date Firm Action Rating
2024-04-18 Wedbush Maintains Outperform -> Outperform
2024-04-10 Roth MKM Maintains Neutral -> Neutral
2024-04-10 Benchmark Reiterate Buy -> Buy
2024-04-08 JP Morgan Maintains Neutral -> Neutral
2024-04-05 Wells Fargo Upgrade Underweight -> Overweight
2024-04-03 Benchmark Reiterate Buy -> Buy
2024-02-13 Wedbush Reiterate Outperform -> Outperform
2024-02-06 JP Morgan Maintains Neutral -> Neutral
2024-01-11 Goldman Sachs Maintains Sell -> Sell
2024-01-02 B. Riley Securities Downgrade Buy -> Neutral
2023-12-20 Wells Fargo Downgrade Equal-Weight -> Underweight
2023-10-24 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2023-10-06 Benchmark Maintains Buy -> Buy
2023-09-19 Benchmark Reiterate Buy -> Buy
2023-08-07 Barrington Research Reiterate Outperform -> Outperform
2023-08-07 Wedbush Reiterate Outperform -> Outperform
2023-08-07 Morgan Stanley Maintains Overweight -> Overweight
2023-08-01 Wedbush Reiterate Outperform -> Outperform
2023-07-19 JP Morgan Downgrade Overweight -> Neutral
2023-07-18 Morgan Stanley Reiterate Overweight -> Overweight
2023-07-12 Roth MKM Maintains Neutral -> Neutral
2023-07-12 B. Riley Securities Upgrade Neutral -> Buy
2023-07-10 Benchmark Reiterate Buy -> Buy
2023-06-14 B. Riley Securities Downgrade Buy -> Neutral
2023-05-26 Benchmark Reiterate Buy -> Buy
2023-05-09 Barrington Research Maintains Outperform
2023-05-08 Macquarie Maintains Outperform
2023-05-08 B. Riley Securities Maintains Buy
2023-05-08 Wedbush Reiterate Outperform
2023-05-08 Credit Suisse Reiterate Neutral